Therapeutic Areas 

Parkinson’s Disease Psychosis

Parkinson’s disease psychosis (PDP) is typically characterized by hallucinations and delusions. Around 50% of patients with Parkinson’s disease may experience hallucinations and/or delusions over the course of their disease.

Neuron graphic blue

Alzheimer’s Disease Psychosis

Approximately 6 million people in the United States are living with Alzheimer’s disease with this number projected to rise as the elderly population grows. Hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP) affects around 30% of patients with AD dementia.

Cell graphic blue

Rett Syndrome 

Rett syndrome (RTT) is a rare neurodevelopmental disorder that occurs primarily in females following apparently normal development for the first 6-18 months of life. RTT occurs worldwide in approximately one of every 10,000 to 15,000 female births (6,000 to 9,000 patients in the U.S.).

Neuron graphic blue

Negative Symptoms of Schizophrenia

Patients may experience negative symptoms of schizophrenia (NSS), which may include reduction or absence of behaviors related to motivation and interest or expression.

Cell graphic

Report Adverse Event: If you have an adverse event or product complaint to report, please call contact Acadia Pharmaceuticals Inc. at 1-844-422-2342, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.